24th Mar 2021 12:32
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 23 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,790,295 | 1.39% | 189,753 | 0.15% | ||
(2) | Derivatives (other than options): | ||||
102,935 | 0.08% | 7,066 | 0.01% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
| TOTAL: | |||||
1,899,330 | 1.47% | 202,919 | 0.16% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 221.5000 USD |
| Purchase | 1 | 222.5100 USD |
| Purchase | 19 | 221.8800 USD |
| Purchase | 33 | 222.2400 USD |
| Purchase | 100 | 223.0400 USD |
| Purchase | 100 | 223.1300 USD |
| Purchase | 100 | 222.2300 USD |
| Purchase | 200 | 222.2475 USD |
| Purchase | 246 | 221.8085 USD |
| Purchase | 300 | 221.1418 USD |
| Purchase | 392 | 221.4400 USD |
| Purchase | 400 | 221.5075 USD |
| Purchase | 478 | 222.3896 USD |
| Purchase | 1,855 | 221.4876 USD |
| Purchase | 2,066 | 221.7052 USD |
| Purchase | 2,600 | 221.9823 USD |
| Purchase | 6,687 | 222.0402 USD |
| Purchase | 7,378 | 222.0485 USD |
| Purchase | 9,042 | 221.9501 USD |
| Purchase | 9,323 | 221.4884 USD |
| Purchase | 12,078 | 221.4900 USD |
| Purchase | 20,883 | 221.8603 USD |
| Purchase | 22,091 | 221.7520 USD |
| Sale | 4 | 221.8162 USD |
| Sale | 19 | 221.8800 USD |
| Sale | 23 | 222.0000 USD |
| Sale | 100 | 220.7600 USD |
| Sale | 100 | 222.3900 USD |
| Sale | 100 | 222.4100 USD |
| Sale | 109 | 221.7002 USD |
| Sale | 176 | 221.9900 USD |
| Sale | 200 | 221.5550 USD |
| Sale | 200 | 222.2475 USD |
| Sale | 200 | 222.1000 USD |
| Sale | 201 | 222.0966 USD |
| Sale | 203 | 221.8750 USD |
| Sale | 246 | 221.8085 USD |
| Sale | 300 | 222.0400 USD |
| Sale | 300 | 221.9016 USD |
| Sale | 300 | 222.0383 USD |
| Sale | 311 | 221.8509 USD |
| Sale | 400 | 221.8418 USD |
| Sale | 467 | 221.9105 USD |
| Sale | 496 | 222.0079 USD |
| Sale | 500 | 222.3220 USD |
| Sale | 500 | 221.6670 USD |
| Sale | 597 | 222.0792 USD |
| Sale | 828 | 221.9800 USD |
| Sale | 869 | 221.4512 USD |
| Sale | 900 | 222.0972 USD |
| Sale | 1,747 | 221.8118 USD |
| Sale | 1,854 | 221.4875 USD |
| Sale | 2,100 | 221.9457 USD |
| Sale | 2,238 | 221.6645 USD |
| Sale | 6,777 | 222.0593 USD |
| Sale | 6,860 | 221.9788 USD |
| Sale | 7,563 | 222.0558 USD |
| Sale | 8,993 | 222.0725 USD |
| Sale | 10,821 | 222.0292 USD |
| Sale | 11,603 | 221.5220 USD |
| Sale | 26,807 | 221.4900 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure | 24 March 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210324005533/en/
Copyright Business Wire 2021
Related Shares:
Barclays